Clinical Trials
6 trialsNCT05461430 2026-04-13
TraveraRTGx
Travera Inc
Completed
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT03329950 2024-03-28
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Celldex Therapeutics
Phase 1 Completed
NCT03602079 2023-08-03
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Klus Pharma Inc.
Phase 1/2 Completed
NCT00743262 2023-07-25
Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis
Atos Medical AB
Phase 1/2 Completed
NCT01045057 2021-06-11
Clinical Feasibility of New Tracheoesophageal Puncture Set
Atos Medical AB
Phase NA Completed